XML 13 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Investments
9 Months Ended
Oct. 31, 2019
Investments, Debt and Equity Securities [Abstract]  
Investments Investments
Marketable Securities
At October 31, 2019, marketable securities consisted of the following (in millions):
Investments classified as Marketable SecuritiesAmortized
Cost
Unrealized
Gains
Unrealized
Losses
Fair Value
Corporate notes and obligations$1,555  $ $(1) $1,559  
U.S. treasury securities302    303  
Mortgage backed obligations91    91  
Asset backed securities455    456  
Municipal securities111    112  
Foreign government obligations52    52  
U.S. agency obligations12    12  
Time deposits    
Covered bonds73    73  
Total marketable securities$2,654  $ $(1) $2,661  
At January 31, 2019, marketable securities consisted of the following (in millions):
Investments classified as Marketable SecuritiesAmortized
Cost
Unrealized
Gains
Unrealized
Losses
Fair Value
Corporate notes and obligations$1,027  $ $(8) $1,019  
U.S. treasury securities89   (1) 88  
Mortgage backed obligations79   (1) 78  
Asset backed securities245   (1) 244  
Municipal securities104    104  
Foreign government obligations58   (1) 57  
U.S. agency obligations    
Time deposits    
Covered bonds75    75  
Total marketable securities$1,685  $ $(12) $1,673  
The contractual maturities of the investments classified as marketable securities are as follows (in millions):
 As of
 October 31, 2019January 31, 2019
Due within 1 year$1,196  $482  
Due in 1 year through 5 years1,463  1,189  
Due in 5 years through 10 years  
$2,661  $1,673  
As of October 31, 2019, the following marketable securities were in an unrealized loss position (in millions):
 Less than 12 Months12 Months or GreaterTotal
 Fair ValueUnrealized
Losses
Fair ValueUnrealized
Losses
Fair ValueUnrealized
Losses
Corporate notes and obligations$ $ $98  $(1) $98  $(1) 
The unrealized losses for each of the fixed rate marketable securities were less than $1 million. The Company does not believe any of the unrealized losses represent an other-than-temporary impairment based on its evaluation of available evidence as of October 31, 2019, such as the Company's intent to hold the investment and whether it is more likely than not that the Company will be required to sell the investment before recovery of the investment's amortized basis. The Company expects to receive the full principal and interest on all of these marketable securities.
Investment Income
Investment income consists of interest income, realized gains and realized losses on the Company’s cash, cash equivalents and marketable securities. The components of investment income are presented below (in millions):
 Three Months Ended October 31,Nine Months Ended October 31,
 2019201820192018
Interest income$32  $13  $89  $45  
Realized gains    
Realized losses  (1) (5) 
Investment income$32  $13  $89  $41  
Strategic Investments
Strategic investments by form and measurement category as of October 31, 2019 were as follows (in millions):
 Measurement Category
 Fair ValueMeasurement AlternativeOtherTotal
Equity securities$365  $1,317  $41  $1,723  
Debt securities  37  37  
Balance as of October 31, 2019$365  $1,317  $78  $1,760  
Strategic investments by form and measurement category as of January 31, 2019 were as follows (in millions):
 Measurement Category
 Fair ValueMeasurement AlternativeOtherTotal
Equity securities$436  $785  $50  $1,271  
Debt securities  31  31  
Balance as of January 31, 2019$436  $785  $81  $1,302  
Measurement Alternative Adjustments
The components of privately held equity securities accounted for under the measurement alternative included in the table above are presented below (in millions):
Three Months Ended October 31,Nine Months Ended October 31,
2019201820192018
Carrying amount, beginning of period$917  $667  $785  $548  
Adjustments related to privately held equity securities:
Net additions (1)322  25  333  55  
Upward adjustments81  20  253  132  
Impairments and downward adjustments(3) (1) (54) (24) 
Carrying amount, end of period$1,317  $711  $1,317  $711  
(1) Net additions includes additions from purchases and reductions due to exits of securities and reclassifications due to changes to capital structure.
Since the adoption of ASU 2016-01 on February 1, 2018, cumulative impairments and downward adjustments were $86 million and cumulative upward adjustments were $427 million through October 31, 2019.
Gains (losses) on strategic investments, net
The components of gains and losses on strategic investments are presented below (in millions):
3Three Months Ended October 31,Nine Months Ended October 31,
2019201820192018
Unrealized gains (losses) recognized on publicly traded equity securities, net $(84) $(14) $132  $262  
Unrealized gains recognized on privately held equity securities, net  77  18  199  99  
Realized gains on sales of equity securities, net14  59  76  68  
Losses on debt securities, net(1)  (11) (12) 
Gains on strategic investments, net$ $63  $396  $417  
Realized gains on sales of equity securities, net reflects the difference between the sale proceeds and the carrying value of the equity security at the beginning of the period or the purchase date, if later. The cumulative net gain, measured as the sale price less the initial purchase price, for equity securities exited during the three and nine months ended October 31, 2019 was $152 million and $336 million, respectively. During the three months ended October 31, 2019, the Company sold its investments in three publicly traded companies resulting in a realized loss of $32 million, and a cumulative net gain of $110 million.
Net gains (losses) recognized in the three and nine months ended October 31, 2019 for investments still held as of October 31, 2019 were a loss of $9 million and a gain of $283 million, respectively.
In September 2019, the Company made a strategic investment of $300 million in cash for preferred shares of a technology company in a private placement. The investment was made as part of the Company's overall strategy of investing in complementary companies to facilitate potential alignment and integration into the Company’s offerings or product features. The investment is accounted for using the measurement alternative.